Validity of Meta-Analytical Data on Cutaneous Adverse Events With Phosphoinositide 3-Kinase Inhibitors
JAMA Oncol
.
2023 Oct 1;9(10):1462.
doi: 10.1001/jamaoncol.2023.3384.
Authors
Dan-Na Wu
1
,
Guo Yu
2
,
Guo-Fu Li
2
Affiliations
1
Department of Pharmacy, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, Hainan, China.
2
School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.
PMID:
37651115
DOI:
10.1001/jamaoncol.2023.3384
No abstract available